BTIG says favors medical device makers tied to elective procedures

RxSight

18/04/2022 13:39

** In its Q1 preview note for the medical device sector,
BTIG says favors medical device makers that are tied to elective
procedure as the brokerage believes they are best suited to move
higher in Q2 and beyond 
    ** Despite COVID dynamics being in the rear-view, many
companies are wrestling with inflation, supply chain dynamics
and broader Russia-Ukraine reverberations, making most investors
not feeling great about upcoming earnings season, BTIG says 
    ** S&P health care equipment & services index   .SPLRCHC 
down 1.57% YTD through Thursday close vs ~8% fall in S&P 500
index  .SPX 
    ** BTIG says Abbott Laboratories  ABT.N , due to report
earns on Wed, can likely manage near-term inflationary pressures
and some device procedures that were impacted by Omicron
hospitalizations may have shown signs of fast recovery in March
    ** Also picks STAAR Surgical  STAA.O , Glaukos  GKOS.N  and
RxSight  RXST.O  to do well in the quarter
     

 (Reporting by Ankur Banerjee)